Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112465418 | 11246541 | 8 | F | 201507 | 20160722 | 20150708 | 20160729 | EXP | US-ELI_LILLY_AND_COMPANY-US201506005544 | ELI LILLY AND CO | 79.20 | YR | F | Y | 0.00000 | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112465418 | 11246541 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Oral | 40 MG, QD | C366683A | 21368 | 40 | MG | TABLET | QD | |||||
| 112465418 | 11246541 | 2 | I | ADCIRCA | TADALAFIL | 1 | Oral | 40 MG, QD | C398383A | 21368 | 40 | MG | TABLET | QD | |||||
| 112465418 | 11246541 | 3 | I | ADCIRCA | TADALAFIL | 1 | Oral | 40 MG, QD | C459623A | 21368 | 40 | MG | TABLET | QD | |||||
| 112465418 | 11246541 | 4 | I | LETAIRIS | AMBRISENTAN | 1 | Unknown | UNK, UNKNOWN | Y | 0 | |||||||||
| 112465418 | 11246541 | 5 | SS | TRAMADOL. | TRAMADOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 112465418 | 11246541 | 6 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, UNKNOWN | 0 | 20 | MG | ||||||||
| 112465418 | 11246541 | 7 | C | IRBESARTAN. | IRBESARTAN | 1 | Oral | 75 MG, UNKNOWN | U | U | 0 | 75 | MG | ||||||
| 112465418 | 11246541 | 8 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | UNK, OTHER (20 MEO) | U | U | 0 | ||||||||
| 112465418 | 11246541 | 9 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, UNKNOWN | U | U | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112465418 | 11246541 | 1 | Pulmonary arterial hypertension |
| 112465418 | 11246541 | 4 | Product used for unknown indication |
| 112465418 | 11246541 | 5 | Product used for unknown indication |
| 112465418 | 11246541 | 6 | Peripheral swelling |
| 112465418 | 11246541 | 7 | Product used for unknown indication |
| 112465418 | 11246541 | 8 | Product used for unknown indication |
| 112465418 | 11246541 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112465418 | 11246541 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112465418 | 11246541 | Amnesia | |
| 112465418 | 11246541 | Arthralgia | |
| 112465418 | 11246541 | Asthenia | |
| 112465418 | 11246541 | Drug interaction | |
| 112465418 | 11246541 | Dyspnoea | |
| 112465418 | 11246541 | Fluid retention | |
| 112465418 | 11246541 | Gait disturbance | |
| 112465418 | 11246541 | Mental disorder | |
| 112465418 | 11246541 | Musculoskeletal pain | |
| 112465418 | 11246541 | Nausea | |
| 112465418 | 11246541 | Oedema | |
| 112465418 | 11246541 | Pain | |
| 112465418 | 11246541 | Pain in extremity | |
| 112465418 | 11246541 | Peripheral swelling | |
| 112465418 | 11246541 | Somnolence | |
| 112465418 | 11246541 | Vision blurred | |
| 112465418 | 11246541 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112465418 | 11246541 | 1 | 20150602 | 0 | ||
| 112465418 | 11246541 | 4 | 201504 | 0 |